Dynamic relationship between IFN-γ and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load

Journal of Immunology

Volumn 178, Issue 8, 2007, Pages 5217-5226

  Millington, Kerry A ^a,b   Innes, John A ^c   Hackforth, Sarah ^c   Hinks, Timothy S C ^b   Deeks, Jonathan J ^d   Dosanjh, Davinder P S ^b   Guyot Revol, Valerie ^b   Gunatheesan, Rubamalaar ^b   Klenerman, Paul ^b   Lalvani, Ajit ^a,b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL KINETICS; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CODOMINANCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TUBERCULOSIS;

EID: 34247137553     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.8.5217     Document Type: Article

References (50)

1. Sprent, J., and C. D. Surh. 2002. T cell memory. Annu. Rev. Immunol. 20: 551-579.
2. + effector and memory T cell generation. Nat. Immunol. 4: 835-842.
3. Ahmed, R., and D. Gray. 1996. Immunological memory and protective immunity: understanding their relation. Science 272: 54-60.
4. Lanzavecchia, A., and F. Sallusto. 2000. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 290: 92-97.
5. Lanzavecchia, A., and F. Sallusto. 2002. Progressive differentiation and selection of the fittest in the immune response. Nat. Rev. Immunol. 2: 982-987.
6. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
7. Emu, B., E. Sinclair, D. Favre, W. J. Moretto, P. Hsue, R. Hoh, J. N. Martin, D. F. Nixon, J. M. McCune, and S. G. Deeks. 2005. Phenotypic, functional, and - kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment. J. Virol. 79: 14169-14178.
8. Harari, A., F. Vallelian, P. R. Meylan, and G. Pantaleo. 2005. Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J. Immunol. 174: 1037-1045.
9. + T cells endowed with proliferative capacity. J. Exp. Med. 198: 1909-1922.
10. Day, C. L., and B. D. Walker. 2003. Progress in defining CD4 helper cell responses in chronic viral infections. J. Exp. Med. 198: 1773-1777.
11. + T helper cells in chronic HCV infection. Hepatology 41: 1019-1028.
12. + T cell help distinguishes HIV-2 from HIV-1 infection. J. Immunol. 176:6973-6981.
13. Lucas, M., C. L. Day, J. R. Wyer, S. L. Cunliffe, A. Loughry, A. J. McMichael, and P. Klenerman. 2004. Ex vivo phenotype and frequency of influenza virus-specific CD4 memory T cells. J. Virol. 78: 7284-7287.
14. Pantaleo, G., and A. Harari. 2006. Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. Nat. Rev. Immunol. 6: 417-423.
15. Lalvani, A., P. Nagvenkar, Z. Udwadia, A. A. Pathan, K. A. Wilkinson, J. S. Shastri, K. Ewer, A. V. Hill, A. Mehta, and C. Rodrigues. 2001. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J. Infect. Dis. 183: 469-477.
16. Pathan, A. A., K. A. Wilkinson, P. Klenerman, H. McShane, R. N. Davidson, G. Pasvol, A. V. Hill, and A. Lalvani. 2001. Direct ex vivo analysis of antigen-specific IFN-γ-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J. Immunol. 167: 5217-5225.
17. Carrara, S., D. Vincenti, N. Petrosillo, M. Amicosante, E. Girardi, and D. Goletti. 2004. Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin. Infect. Dis. 38: 754-756.
18. Nicol, M. P., D. Pienaar, K. Wood, B. Eley, R. I. Wilkinson, H. Henderson, L. Smith, S. Samodien, and D. Beatty. 2005. Enzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: implications for diagnosis and monitoring of therapy. Clin. Infect. Dis. 40: 1301-1308.
19. Behr, M. A., M. A. Wilson, W. P. Gill, H. Salamon, G. K. Schoolnik, S. Rane, and P. M. Small. 1999. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284: 1520-1523.
20. Ewer, K., J. Deeks, L. Alvarez, G. Bryant, S. Waller, P. Andersen, P. Monk, and A. Lalvani. 2003. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 361: 1168-1173.
21. Twisk, J. 2003. Applied Longitudinal Data Analysis for Epidemiology: A Practical Guide. Cambridge University Press, Cambridge.
22. e scale simplify the presentation of log transformed data. Stat. Med. 19: 3109-3125.
23. 2000. Diagnostic standards and classification of tuberculosis in adults and children: this official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am. J. Respir. Crit. Care Med. 161: 1376-1395.
24. 2000. Control and prevention of tuberculosis in the United Kingdom: code of practice 2000: Joint Tuberculosis Committee of the British Thoracic Society. Thorax 55: 887-901.
25. Lalvani, A., A. A. Pathan, H. McShane, R. J. Wilkinson, M. Latif, C. P. Conlon, G. Pasvol, and A. V. Hill. 2001. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am. J. Respir. Crit. Care Med. 163: 824-828.
26. Lalvani, A., A. A. Pathan, H. Durkan, K. A. Wilkinson, A. Whelan, J. J. Deeks, W. H. Reece, M. Latif, G. Pasvol, and A. V. Hill. 2001. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 357: 2017-2021.
27. Chapman, A. L., M. Munkanta, K. A. Wilkinson, A. A. Pathan, K. Ewer, H. Ayles, W. H. Reece, A. Mwinga, P. Godfrey-Faussett, and A. Lalvani. 2002. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 16: 2285-2293.
28. Klenerman, P., V. Cerundolo, and P. R. Dunbar. 2002. Tracking T cells with tetramers: new tales from new tools. Nat. Rev. Immunol. 2: 263-272.
29. Sester, M., U. Sester, B. Gartner, G. Heine, M. Girndt, N. Mueller-Lantzsch, A. Meyerhans, and H. Kohler. 2001. Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation. Transplantation 71: 1287-1294.
30. + T cells based on cytokine secretion. Eur. J. Immunol. 29: 4053-4059.
31. + T cells based on cytokine secretion. Methods 31: 150-159.
32. + T cells in the context of multiple HLA alleles. J. Immunol. 173: 1966-1977.
33. Aiken, A. M., P. C. Hill, A. Fox, K. P. McAdam, D. J. Jackson-Sillah, M. D. Lugos, S. A. Donkor, R. A. Adegbola, and R. H. Brookes. 2006. Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infect. Dis. 6: 66.
34. Wilkinson, R. J., H. M. Vordermeier, K. A. Wilkinson, A. Sjolund, C. Moreno, G. Pasvol, and J. Ivanyi. 1998. Peptide-specific T cell response to Mycobacterium tuberculosis: clinical spectrum, compartmentalization, and effect of chemotherapy. J. Infect. Dis. 178: 760-768.
35. Hirsch, C. S., Z. Toossi, C. Othieno, J. L. Johnson, S. K. Schwander, S. Robertson, R. S. Wallis, K. Edmonds, A. Okwera, R. Mugerwa, et al. 1999. Depressed T-cell interferon-γ responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J. Infect. Dis. 180: 2069-2073.
36. Vekemans, J., C. Lienhardt, J. S. Sillah, J. G. Wheeler, G. P. Lahai, M. T. Doherty, T. Corrah, P. Andersen, K. P. McAdam, and A. Marchant. 2001. Tuberculosis contacts but not patients have higher γ interferon responses to ESAT-6 than do community controls in The Gambia. Infect. Immun. 69: 6554-6557.
37. Al-Attiyah, R., A. S. Mustafa, A. T. Abal, N. M. Madi, and P. Andersen. 2003. Restoration of mycobacterial antigen-induced proliferation and interferon-γ responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy. FEMS Immunol. Med. Microbiol. 38: 249-256.
38. Ferrand, R. A., G. H. Bothamley, A. Whelan, and H. M. Dockrell. 2005. Interferon-γ responses to ESAT-6 in tuberculosis patients early into and after antituberculosis treatment. Int. J. Tuberc. Lung Dis. 9: 1034-1039.
39. + memory T cells. J. Exp. Med. 186: 859-865.
40. Lalvani, A. 2004. Counting antigen-specific T cells: a new approach for monitoring response to tuberculosis treatment? Clin. Infect. Dis. 38: 757-759.
41. + T cells after clearance of hepatitis C virus. J. Immunol. 169: 2210-2214.
42. Gelband, H. 2000. Regimens of less than six months for treating tuberculosis. Cochrane Database Syst. Rev. CD001362.
43. Harari, A., F. Vallelian, and G. Pantaleo. 2004. Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load. Eur. J. Immunol. 34: 3525-3533.
44. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178: 2249-2254.
45. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in interferon γ gene-disrupted mice. J. Exp. Med. 178: 2243-2247.
46. Ottenhoff, T. H., D. Kumararatne, and J. L. Casanova. 1998. Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria. Immunol. Today 19: 491-494.
47. Malek, T. R., and A. L. Bayer. 2004. Tolerance, not immunity, crucially depends on IL-2. Nat. Rev. Immunol. 4: 665-674.
48. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22: 531-562.
49. Guyot-Revol, V., J. A. Innes, S. Hackforth, T. Hinks, and A. Lalvani. 2006. Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am. J. Respir. Crit. Care Med. 173: 803-810.
50. Richeldi, L., K. Ewer, M. Losi, B. M. Bergamini, P. Roversi, J. Deeks, L. M. Fabbri, and A. Lalvani. 2004. T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure. Am. J. Respir. Crit. Care Med. 170: 288-295.